Evoke Pharma Inc (EVOK)
4.366
+0.11
(+2.48%)
USD |
NASDAQ |
Nov 14, 16:00
4.56
+0.19
(+4.45%)
After-Hours: 20:00
Evoke Pharma Gross Profit (Annual): 4.979M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.979M |
| December 31, 2022 | 2.138M |
| December 31, 2021 | 1.29M |
| December 31, 2020 | -0.0637M |
| December 31, 2019 | 0.00 |
| December 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
-0.0637M
Minimum
2020
4.979M
Maximum
2023
1.669M
Average
1.29M
Median
2021
Gross Profit (Annual) Benchmarks
| Repligen Corp | 284.84M |
| Eli Lilly and Co | 27.04B |
| MEI Pharma Inc | -- |
| Revance Therapeutics Inc | 159.68M |
| NovaBay Pharmaceuticals Inc | 7.895M |